6-methoxy-3,8-dimethyl-N-(piperidin-4-ylmethyl)-1H-pyrazolo[3,4-b]quinolin-4-amine

ID: ALA1939810

PubChem CID: 46239123

Max Phase: Preclinical

Molecular Formula: C19H25N5O

Molecular Weight: 339.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C)c2nc3[nH]nc(C)c3c(NCC3CCNCC3)c2c1

Standard InChI:  InChI=1S/C19H25N5O/c1-11-8-14(25-3)9-15-17(11)22-19-16(12(2)23-24-19)18(15)21-10-13-4-6-20-7-5-13/h8-9,13,20H,4-7,10H2,1-3H3,(H2,21,22,23,24)

Standard InChI Key:  OMCOUOOGAGOGRF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
   10.1768   -4.7184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1756   -5.5454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8902   -5.9580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8884   -4.3058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6033   -4.7148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6041   -5.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3190   -5.9520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3134   -4.3008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0290   -4.7078    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0367   -5.5389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8295   -5.7884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3118   -5.1114    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.8170   -4.4438    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0916   -6.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8859   -3.4813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4613   -5.9571    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7521   -5.5442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3193   -6.7766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0337   -7.1886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0291   -8.0136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3101   -8.4182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3036   -9.2396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0140   -9.6599    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7325   -9.2526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7407   -8.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
  3  6  2  0
 11 14  1  0
  6  7  1  0
  4 15  1  0
  7 10  2  0
  2 16  1  0
  1  2  2  0
 16 17  1  0
  9  8  2  0
  7 18  1  0
  8  5  1  0
 18 19  1  0
 19 20  1  0
  9 10  1  0
 20 21  1  0
  5  4  2  0
  4  1  1  0
  2  3  1  0
  5  6  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
M  END

Associated Targets(Human)

PDE6H Tclin Phosphodiesterase 6 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE10A Tclin Phosphodiesterase 10A (5542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 339.44Molecular Weight (Monoisotopic): 339.2059AlogP: 3.15#Rotatable Bonds: 4
Polar Surface Area: 74.86Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.49CX Basic pKa: 10.32CX LogP: 1.67CX LogD: -0.89
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.68Np Likeness Score: -0.79

References

1. Ho GD, Yang SW, Smotryski J, Bercovici A, Nechuta T, Smith EM, McElroy W, Tan Z, Tulshian D, McKittrick B, Greenlee WJ, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R..  (2012)  The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.,  22  (2): [PMID:22222034] [10.1016/j.bmcl.2011.11.127]

Source